A clinical investigation using reflectance confocal microscopy to evaluate the add-on efficacy of the Shumin treatment instrument combined with doxycycline for rosacea - Report - MDSpire
Advertisement
A clinical investigation using reflectance confocal microscopy to evaluate the add-on efficacy of the Shumin treatment instrument combined with doxycycline for rosacea
Clinical Report: Evaluation of Shumin Device and Doxycycline in Rosacea
Overview
This study evaluates the effectiveness and safety of combining the Shumin treatment device with doxycycline versus doxycycline with red light therapy in treating rosacea. Results indicate a higher efficacy rate and improved quality of life in the experimental group using the Shumin device.
Background
Rosacea is a chronic inflammatory skin condition that significantly impacts patients' quality of life and is often challenging to treat. The study addresses the need for effective treatment strategies by comparing two adjunctive therapies to oral doxycycline. Understanding the efficacy of these combined treatments can help optimize management for patients suffering from rosacea.
Data Highlights
Group
Efficacy Rate
Dermatology Life Quality Index Improvement
Demodex Count Reduction
Relapse Rate
Shumin Device + Doxycycline
93.3%
Superior Improvement
No Significant Difference
Lower (p = 0.026)
Red Light Therapy + Doxycycline
80.0%
Improvement
No Significant Difference
Higher
Key Findings
The experimental group (Shumin device) had a 93.3% efficacy rate compared to 80.0% in the control group (red light therapy).
Both groups showed significant reductions in Dermatology Life Quality Index scores (p < 0.001).
Improvements in affected hair follicle counts were significantly better in the experimental group (p < 0.05).
No significant difference in total Demodex count reduction was observed between the groups.
The relapse rate was significantly lower in the experimental group (p = 0.026).
Clinical Implications
The findings suggest that the Shumin treatment device may offer superior clinical outcomes when used alongside doxycycline for rosacea management. Clinicians may consider this combination as a viable option for improving patient quality of life and reducing relapse rates.
Conclusion
The Shumin device, when used in conjunction with doxycycline, demonstrates improved efficacy and safety compared to red light therapy for treating rosacea. These results support further exploration of combined treatment strategies.
A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness
Phones in class, a 25-year prescription gone wrong, pickleball's hidden danger, and why your spin class is too loud — four findings hiding in everyday care.
